Literature DB >> 1851084

Endocrine factors in common epithelial ovarian cancer.

B R Rao1, B J Slotman.   

Abstract

Entities:  

Keywords:  Biology; Cancer; Developed Countries; Diseases; Europe; Hormone Receptors; Literature Review; Membrane Proteins; Neoplasms; Ovarian Cancer--etiology; Physiology; Treatment

Mesh：

Substances：

Year:  1991        PMID： 1851084     DOI： 10.1210/edrv-12-1-14

Source DB:  PubMed          Journal:  Endocr Rev        ISSN： 0163-769X            Impact factor:   19.871


× No keyword cloud information.
  34 in total

Review 1.  Estrogen receptor beta, a possible tumor suppressor involved in ovarian carcinogenesis.

Authors:  Gwendal Lazennec
Journal:  Cancer Lett       Date:  2006-01-18       Impact factor: 8.679

2.  Immunohistochemical analysis of 17β-hydroxysteroid dehydrogenase isozymes in human ovarian surface epithelium and epithelial ovarian carcinoma.

Authors:  Ken-ichi Motohara; Hironori Tashiro; Yumiko Taura; Takashi Ohba; Hidetaka Katabuchi
Journal:  Med Mol Morphol       Date:  2011-01-26       Impact factor: 2.309

3.  MAPK Activation Predicts Poor Outcome and the MEK Inhibitor, Selumetinib, Reverses Antiestrogen Resistance in ER-Positive High-Grade Serous Ovarian Cancer.

Authors:  Karina E Hew; Philip C Miller; Dorraya El-Ashry; Jun Sun; Alexandra H Besser; Tan A Ince; Mengnan Gu; Zhi Wei; Gao Zhang; Patricia Brafford; Wei Gao; Yiling Lu; Gordon B Mills; Joyce M Slingerland; Fiona Simpkins
Journal:  Clin Cancer Res       Date:  2015-10-19       Impact factor: 12.531

4.  Estradiol regulates E-cadherin mRNA levels in the surface epithelium of the mouse ovary.

Authors:  C D MacCalman; R Farookhi; O W Blaschuk
Journal:  Clin Exp Metastasis       Date:  1994-07       Impact factor: 5.150

5.  Cytokeratin 5-Positive Cells Represent a Therapy Resistant subpopulation in Epithelial Ovarian Cancer.

Authors:  Bradley R Corr; Jessica Finlay-Schultz; Rachel B Rosen; Lubna Qamar; Miriam D Post; Kian Behbakht; Monique A Spillman; Carol A Sartorius
Journal:  Int J Gynecol Cancer       Date:  2015-11       Impact factor: 3.437

6.  Cellular distribution of retinoic acid receptor-alpha protein in serous adenocarcinomas of ovarian, tubal, and peritoneal origin: comparison with estrogen receptor status.

Authors:  C D Katsetos; I Stadnicka; J C Boyd; H Ehya; S Zheng; C M Soprano; H S Cooper; A S Patchefsky; D R Soprano; K J Soprano
Journal:  Am J Pathol       Date:  1998-08       Impact factor: 4.307

7.  Relationship between epidemiologic risk factors and hormone receptor expression in ovarian cancer: results from the Nurses' Health Study.

Authors:  Jonathan L Hecht; Joanne Kotsopoulos; Susan E Hankinson; Shelley S Tworoger
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2009-04-21       Impact factor: 4.254

Review 8.  Hormone response in ovarian cancer: time to reconsider as a clinical target?

Authors:  Francesmary Modugno; Robin Laskey; Ashlee L Smith; Courtney L Andersen; Paul Haluska; Steffi Oesterreich
Journal:  Endocr Relat Cancer       Date:  2012-11-09       Impact factor: 5.678

9.  Tamoxifen and the risk of ovarian cancer in BRCA1 mutation carriers.

Authors:  Danielle Vicus; Barry Rosen; Jan Lubinski; Susan Domchek; Noah D Kauff; Henry T Lynch; Claudine Isaacs; Nadine Tung; Ping Sun; Steven A Narod
Journal:  Gynecol Oncol       Date:  2009-07-03       Impact factor: 5.482

10.  Proliferation of the superficial epithelium of ovaries in senile female rats following oral administration of conjugated equine estrogens.

Authors:  Sergio Eduardo Perniconi; Manuel de Jesus Simões; Ricardo Dos Santos Simões; Mauro Abi Haidar; Edmund C Baracat; Jose Maria Soares
Journal:  Clinics (Sao Paulo)       Date:  2008-06       Impact factor: 2.365
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.